Medifast, Inc. MED is scheduled to report third-quarter 2019 numbers on Nov 7.
The company’s earnings outperformed the Zacks Consensus Estimate by 5.6%, on average, over the trailing four quarters. In the last reported quarter, it witnessed a positive earnings surprise of 2.3%.
The Zacks Consensus Estimate for third-quarter earnings is pegged at $1.33 per share, suggesting growth of 16.7% from the year-ago quarter’s reported figure. The consensus mark for the same has been unchanged over the past 30 days. The consensus mark for revenues is pegged at $194.4 million, suggesting an increase of 39.6% from the year-ago quarter’s reported figure.
MEDIFAST INC Price and EPS Surprise
MEDIFAST INC price-eps-surprise | MEDIFAST INC Quote
Key Factors to Note
Medifast has been witnessing consistent growth in OPTAVIA-branded products. Further, growth in active earning coaches has been aiding the company.
On its last earnings call, management had projected revenues of $190-$195 million for the third quarter, which suggests an increase from $139 million reported in the prior-year quarter.
The company’s pricing actions to improve gross margin are expected to have aided its performance in the third quarter. Management forecasted adjusted earnings of $1.3-$1.35 for the third quarter, which suggests an improvement from $1.14 reported in the year-ago quarter.
Moreover, Medifast’s top line in the third quarter is expected to reflect gains from the introduction of its new mobile platform.
However, increased expenses related to the convention held in July and higher IT spend, owing to the implementation of the ERP process, might get reflected in Medifast’s bottom line in the quarter under review.
Our proven model doesn’t conclusively predict an earnings beat for Medifast this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here.
The company carries a Zacks Rank #3 (Hold) and Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks With Favorable Combination
Here are some companies you may want to consider as our model shows that these have the right combination of elements to post an earnings beat:
Foot Locker FL has an Earnings ESP of +2.80% and a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Grocery Outlet Holding GO currently has an Earnings ESP of +2.70% and a Zacks Rank #2.
Ollie’s Bargain Outlet Holdings OLLI presently has an Earnings ESP of +3.45% and a Zacks Rank #3.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.5% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Ollie's Bargain Outlet Holdings, Inc. (OLLI) : Free Stock Analysis Report
MEDIFAST INC (MED) : Free Stock Analysis Report
Foot Locker, Inc. (FL) : Free Stock Analysis Report
Grocery Outlet Holding Corp. (GO) : Free Stock Analysis Report
To read this article on Zacks.com click here.